Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apatinib in elderly advanced gastric cancer
NCT03104283Phase 2Completed
- Sponsor
- Affiliated Hospital of Qinghai University
- Start
- Jun 2017
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Rivoceranib in gastric cancer (GC), gastroesophageal junction adenocarcinoma, sponsored by Affiliated Hospital of Qinghai University. Started Jun 2017; status: completed.
02
Drugs
Rivoceranib
03
Conditions
gastric cancer (GC)gastroesophageal junction adenocarcinoma
Beyond the preview
Go deeper on NCT03104283.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03104283.